Author Archive

New Resources Remind Moms-to-Be of Seafood Benefits

Raw sushi is out, and fish oil supplements are questionable. But regular fish consumption as part of a healthy prenatal diet? That’s a surefire way

Read More

Are Americans Aware of COPD?

Many Americans felt like they knew former first lady Barbara Bush, whose death the country mourned this month. But how much do we as a

Read More

Parkinson’s Patients Face Treatment Delays

A guest blog by Dr. Michael Rezak, M.D., Ph.D. During a recent visit with one of my Parkinson’s patients, we decided he was a good

Read More

Innovation, Access Issues Dominate Biologics & Biosimilars Summit

“I thought maybe I wasn’t very good athletically.”  That was iconic Olympic gold medalist Jackie Joyner-Kersee’s recollection of her first experience with asthma attacks. Joyner-Kersee

Read More

Cost Sharing is Costing Skin Patients their Medication

After spending time and money to see a dermatologist, many patients with acne fail to fill their prescription. Cost sharing is the culprit, according to

Read More

FDA Opens Door to Pregnant Women in Clinical Trials

Nearly 4 million babies are born each year in the United States.  Yet physicians can have remarkably limited data about treating mothers’ health conditions during

Read More

***PRESS RELEASE*** INSTITUTE FOR PATIENT ACCESS STATEMENT ON ICER’S MIGRAINE DRAFT EVIDENCE REPORT

WASHINGTON – Today, the non-profit Institute for Patient Access made the following statement regarding the Institute for Clinical and Economic Review’s (ICER) draft evidence report

Read More

***PRESS RELEASE*** Nationwide, Health Plans Rejected Almost 80,000 Claims for High Cholesterol Treatment

National health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations WASHINGTON – The non-profit Institute for Patient Access released a new Health Plan

Read More

Patents, Progress & Patient Access

Could a recent memorandum from the U.S. Patent and Trademark Office impact treatment options for patients?  Washington, DC’s nonprofit Bipartisan Policy Center says: Yes. As

Read More

***PRESS RELEASE*** New Paper “The ICER Myth” Explores Drawbacks of ICER’s Evidence Reports and Their Impact on Patients

ICER has come under scrutiny for its methodology and calculations that impact patient access to approved therapies. WASHINGTON – The nonprofit Institute for Patient Access (IfPA)

Read More
Back to Top